Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Predictors Of Patient Reported Outcomes And Cost Of Care In Younger Men With Newly Diagnosed Prostate Cancer
UroToday.com - In the online version of The Prostate, Dr. Ravishankar Jayadevappa and colleagues from the University of Pennsylvania analyzed the association between race, risk of biochemical recurrence and recovery pattern of patient reported outcomes such as satisfaction with care, HRQoL (generic and prostate-specific) and cost in younger men with newly diagnosed prostate cancer (CaP). The investigators hypothesized that younger African American men will have impaired HRQoL outcomes and will present with higher cost compared to younger Caucasian CaP patients.
generic viagra online
Bio-Inspired Cilia Mix Medical Reagents At Small Scales
The equipment used for biomedical research is shrinking, but the physical properties of the fluids under investigation are not changing. This creates a problem: the reservoirs that hold the liquid are now so small that forces between molecules on the liquid"s surface dominate, and one can no longer shake the container to mix two fluids. Instead, researchers must bide their time and wait for diffusion to occur.
News of the day
FDA Approves Effient To Reduce The Risk Of Heart Attack In Angioplasty Patients
The U.S. Food and Drug Administration has approved the blood-thinning drug Effient tablets (prasugrel) to reduce the risk of blood clots from forming in patients who undergo angioplasty, a common procedure to unblock a clogged coronary artery.
Sexual Health

Roche Launches New PCR Assay For Tuberculosis Testing In South Africa

Roche Diagnostics announced the launch of a new tuberculosis test for South Africa. Worldwide, South Africa is one of the countries with the highest prevalence of tuberculosis. The new kit detects different species of Mycobacterium from human sputum samples using the LightCycler® 2.0 Instrument. The diagnosis of tuberculosis in South Africa relies on smear microscopy and culture methods. Smear microscopy allows for direct detection of acid-fast bacilli (AFB) in the specimen and makes it possible to identify the most infectious patients. Although it provides rapid results and is inexpensive, it is limited by its lack of sensitivity and specificity. Based on the inherent advantages of the LightCycler® system, Roche Applied Science, South Africa has developed a LightCycler® assay that overcomes these problems. The LightCycler® Mycobacterium Detection Kit was thoroughly tested in extended analytical and clinical trials together with the National Health Laboratory Services (NHLS) (Pretoria and Kimberley Laboratories), South Africa, and at the University Hospital in Regensburg, Germany. The new test offers a number of advantages over current testing methods: it enables differentiation between Mycobacterium tuberculosis, Mycobacterium avium, and Mycobacterium kansasii in a single PCR run, and provides laboratories with reliable, accurate and objective results within hours, significantly improving patient management. Replacing the AFB smear test will significantly reduce false negative results obtained by microscopy. Use of the new test will result in fewer cultures being performed, leading to significant improvements in turnaround times for the patient. The test sequence is convenient and easy to perform; the throughput of the system suits low, medium and high throughput sample sites. "We are proud of our contribution in the battle against tuberculosis, which is really a plague in African countries. Every patient should get exactly what he needs to be cured - this is Roche"s basic idea of Personalized Healthcare. A fast, safe test result is the backbone of this concept." said Manfred Baier, Head of Roche Applied Science. Roche is currently evaluating which countries besides South Africa would also be suitable candidates for the test. Tuberculosis is one of the major causes of death from infectious diseases worldwide, killing nearly 2 million people each year. It is also the most common cause of death in developing countries for individuals infected with the human immunodeficiency virus (HIV), particularly among patients with sputum smear-negative pulmonary tuberculosis. The increase in the incidence of tuberculosis fueled by the HIV pandemic in sub-Saharan Africa has highlighted the urgent need for rapid diagnosis of tuberculosis. Roche


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009